Ashley Magargee, MBA

In January 2024, Ashley Magargee assumed the role of chief executive officer of Genentech, a member of the Roche Group, and also joined Genentech's Board of Directors. As CEO, Ashley's primary responsibilities are to provide strategic leadership for Genentech, cultivate a vibrant culture that inspires employees to be their best, and bring life-changing medicines to patients.

Ashley was previously head of the Commercial Portfolio Organization, responsible for the overall performance of Genentech's approved medicines in the United States. During her tenure in this role, she successfully launched numerous groundbreaking medicines for people with serious conditions and also expanded the company's presence in several therapeutic areas.

Throughout her nearly two-decade career at Genentech and Roche, Ashley has led global cross-functional teams to develop and commercialize innovative medicines worldwide. She has also been instrumental in shaping the company's digital customer engagement strategy and has held leadership positions in access, marketing and sales leadership for therapeutic areas such as hematology, lung cancer and transplant. Additionally, Ashley served as the general manager for Roche's commercial operations in Singapore and Brunei.

Early in her career, Ashley worked on Capitol Hill focusing on health policy under Senator Tom Daschle, the Democratic Leader of the U.S. Senate. She also served as assistant principal at the St. Mark the Evangelist School in Harlem, where she witnessed firsthand the profound impact of sickle cell disease on her students. These experiences in public service laid a strong foundation for Ashley's subsequent transition into the biopharmaceutical industry. Here, she has sought to leverage the industry's innovation, reach and resources to bring about transformative medicines and healthcare solutions for patients in critical need.

Ashley is a firm believer that encouraging a diversity of background, thought and experience is critical to fueling scientific and customer innovation. She is dedicated to cultivating an environment where all employees are included and empowered; advancing Genentech's commitment to inclusive research and health equity; and transforming society through sustainable solutions that address inequities in healthcare, advance STEM education and support Genentech's local communities.

Ashley serves on the Board of Directors for the Pharmaceutical Research and Manufacturers of America. She graduated from Princeton University and earned her MBA from Harvard University. Ashley resides in the San Francisco Bay Area with her husband and three sons.